Terms: = Cervical cancer AND HRAS, K-ras, 3265, ENSG00000174775, HRAS1, RASH1, c-bas/has, P01112, N-ras AND Prognosis
9 results:
1. DUSP7 inhibits cervical cancer progression by inactivating the RAS pathway.
Bai H; Song M; Jiao R; Li W; Zhao J; Xiao M; Jin M; Zhang Z; Deng H
J Cell Mol Med; 2021 Oct; 25(19):9306-9318. PubMed ID: 34435746
[TBL] [Abstract] [Full Text] [Related]
2. Treatment of consistent BRAF/hras gene mutation and MYC amplification radiation-induced abdominal wall angiosarcoma with low-dose apatinib: a case report.
Guan J; Luo Z; Xiao Z; Xie Y; Lin L
BMC Cancer; 2019 Dec; 19(1):1188. PubMed ID: 31805975
[TBL] [Abstract] [Full Text] [Related]
3. Designing a high-throughput somatic mutation profiling panel specifically for gynaecological cancers.
Spaans VM; Trietsch MD; Crobach S; Stelloo E; Kremer D; Osse EM; Haar NT; van Eijk R; Muller S; van Wezel T; Trimbos JB; Bosse T; Smit VT; Fleuren GJ
PLoS One; 2014; 9(3):e93451. PubMed ID: 24671188
[TBL] [Abstract] [Full Text] [Related]
4. Genetic alterations in the k-ras gene influence the prognosis in patients with cervical cancer treated by radiotherapy.
Wegman P; Ahlin C; Sorbe B
Int J Gynecol Cancer; 2011 Jan; 21(1):86-91. PubMed ID: 21330833
[TBL] [Abstract] [Full Text] [Related]
5. PIK3CA mutations in the kinase domain (exon 20) of uterine endometrial adenocarcinomas are associated with adverse prognostic parameters.
Catasus L; Gallardo A; Cuatrecasas M; Prat J
Mod Pathol; 2008 Feb; 21(2):131-9. PubMed ID: 18084252
[TBL] [Abstract] [Full Text] [Related]
6. H-ras and Nm23-H1 gene expression and proteolytic activity in squamous cell carcinoma of the uterine cervix.
Utrera-Barillas D; Salcedo-Vargas M; Gariglio-Vidal P; Hernández-Hernández DM; Gutiérrez-Delgado F; Benítez-Bribiesca L
Arch Med Res; 2000; 31(2):172-81. PubMed ID: 10880723
[TBL] [Abstract] [Full Text] [Related]
7. Well-differentiated villoglandular adenocarcinoma of the uterine cervix: oncogene/tumor suppressor gene alterations and human papillomavirus genotyping.
Jones MW; Kounelis S; Papadaki H; Bakker A; Swalsky PA; Woods J; Finkelstein SD
Int J Gynecol Pathol; 2000 Apr; 19(2):110-7. PubMed ID: 10782406
[TBL] [Abstract] [Full Text] [Related]
8. [Clinical significance of p21H-ras expression and H-ras codon 12 mutation in squamous intraepithelial lesion (SIL) and carcinoma of uterine cervix].
Li X; Jiao S; Mi R
Zhonghua Zhong Liu Za Zhi; 1997 Jul; 19(4):306-8. PubMed ID: 11038767
[TBL] [Abstract] [Full Text] [Related]
9. Analysis of point mutations at codon 12 of k-ras in human endometrial carcinoma and cervical adenocarcinoma by dot blot hybridization and polymerase chain reaction.
Sato S; Ito K; Ozawa N; Yajima A; Sasano H
Tohoku J Exp Med; 1991 Oct; 165(2):131-6. PubMed ID: 1812593
[TBL] [Abstract] [Full Text] [Related]